SERPINE1 and disease of the tendon: Here, an LPNs platform designed for thecoloading of drugs is loadedwith budesonide and serpine1 siRNA to test it as a dual therapeuticapproach to target the two main dysregulated aspects of macrophagesin tendinopathy, i.e., inflammation and fibrosis.